Supply Agreement Secured - Central American Cannabis Markets
Filed with ASX · · 3 pages · English
• Bioxyne announces its first entry into the emerging medicinal cannabis markets of Costa Rica and Panama through a manufacturing and supply agreement with Remidose LATAM SRL • Agreement ensures first-mover position in high-potential, low-competition Central American markets where non-flower dosage forms like pastilles are expected to dominate • The agreement includes minimum order commitments tha
Earlier from Bioxyne
- Funding from SOSE to Establish UK GMP Manufacturing Facility
- BLS to Manufacture and Distribute Curaleaf International MID
- Presentation on FY2025 Quarter 1 Results
- Initial German Purchase Orders and Import Permits
- BXN Full Year 2026 Guidance
Later from Bioxyne
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4C Revised
- Presentation Results Q2 FY2026
- Half Yearly Report and Accounts
- Stronger H1 FY2026 Performance Upward Revision to Guidance
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne